uniQure said it presented an update on its AMT-130 trials and issued a press release about it. The supplied filing gives no trial findings, so it does not change what we can say about the company’s prospects.
The filing points readers to a presentation and press release, but their trial findings are not included here. Without those details, this notice does not show whether AMT-130 is working or change how the company’s prospects look.
Follow uniQure N.V. (QURE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for QURE